Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Top Cited Papers
- 26 May 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (3) , 434-441
- https://doi.org/10.1016/j.jhep.2005.03.019
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum α‐fetoproteinLiver International, 2004
- Dramatic Reduction of the α-Fetoprotein Level After Lamivudine Treatment of Patients with Chronic Hepatitis B Virus Infection and CirrhosisJournal of Clinical Gastroenterology, 2003
- Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver DiseaseDrugs, 2003
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewHepatology, 2002
- Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis BThe Esophagus, 2002
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusPublished by Elsevier ,2001
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Alpha-Fetoprotein Levels in Normal AdultsThe Lancet Healthy Longevity, 1992
- Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinomaLiver International, 1986
- Serum α-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomyBiochemical Medicine, 1984